KAPA vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 16, 2026

KAPA

50.6
AI Score
VS
CLYM Wins

CLYM

68.1
AI Score

Investment Advisor Scores

KAPA

51score
Recommendation
HOLD

CLYM

68score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric KAPA CLYM Winner
Net Income -3.04M -27.22M KAPA
Operating Income -3.11M -30.57M KAPA
ROE -72.6% -11.4% CLYM
ROA -68.3% -11.1% CLYM
Total Assets 4.46M 246.29M CLYM
Cash 2.63M 44.11M CLYM
Current Ratio 11.98 31.45 CLYM

Relative Price Performance (Last 90 Days)

KAPA 1M: -68.4% · 3M: +80.3% CLYM 1M: -14.3% · 3M: -20.3%

Current Technical Phase

KAPA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 26

RSI (14): 25.9 · Price: $0.56

CLYM

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.1%), weak momentum, RSI 38

RSI (14): 38.2 · Price: $10.19

Fundamentals Snapshot

Metric KAPA CLYM
Market Cap — —
Forward P/E -0.1 -10.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -1.85 -0.80
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.